Viral modulation of the host response via crmA/SPI-2 expression

Immunology and Cell Biology

Volumn 77, Issue 3, 1999, Pages 236-241

  Turner, Stephen ^a   Kenshole, Bronwyn ^a   Ruby, Janet ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Apoptosis; Caspase; crmA SPI 2; Inflammation; Serpin; Virus

Indexed keywords

VIRUS PROTEIN;

ANIMAL CELL; APOPTOSIS; CONFERENCE PAPER; IMMUNE RESPONSE; NONHUMAN; POXVIRUS; VIRUS CELL INTERACTION; VIRUS INFECTION; VIRUS REPLICATION; VIRUS TRANSMISSION;

ANIMALS; APOPTOSIS; CASPASES; HUMANS; INFLAMMATION; INTERLEUKIN-1; INTERLEUKIN-18; PEPTIDES; POXVIRIDAE; SERPINS; VIRAL PROTEINS;

EID: 0032974332     PISSN: 08189641     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1711.1999.00820.x     Document Type: Conference Paper

References (88)

1. 1 Moss, B. Poxviridae: The viruses and their replication. In: Fields B, Knipe D, Howley P (eds). Fields Virology. Philadelphia: Raven Publishers, 1996; 2637-71.
2. 2 McFadden G, Graham K, Ellison K et al. Interruption of cytokine networks by poxviruses: Lessons from myxoma virus. J. Leukoc. Biol. 1995; 57: 731-8.
3. 3 Spriggs MK. One step ahead of the game: Viral immunomodulatory molecules. Annu. Rev. Immunol. 1996; 14: 101-30.
4. 4 Alcami A, Symons J, Khanna A et al. Poxviruses: Capturing cytokines and chemokines. Semin. Virol. 1998; 8: 419-27.
5. 5 McFadden G, Barry M. How poxviruses oppose apoptosis. Semin. Virol. 1998; 8: 429-42.
6. 6 McFadden G, Lalani A, Everett H et al. Virus-encoded receptors for cytokines and chemokines. Semin. Cell Dev. Biol. 1998; 9: 359-68.
7. 7 Smith G, Symons J, Alcami A. Poxviruses: Interfering with interferon. Semin. Virol. 1998; 8: 409-18.
8. 8 Pickup DJ, Ink BS, Hu W et al. Hemorrhage in lesions caused by cowpox virus is induced by a viral protein that is related to plasma protein inhibitors of serine proteases. Proc: Natl Acad. Sci. USA 1986; 83: 7698-702.
9. 9 Palumbo GJ, Pickup DJ, Fredrickson TN et al. Inhibition of an inflammatory response is mediated by a 38-kDa protein of cowpox virus. Virology 1989; 172: 262-73.
10. 10 Ali AN, Turner PC, Brooks MA et al. The SP1-1 gene of rabbitpox virus determines host range and is required for hemorrhagic pock formation. Virology 1994; 202: 305-14.
11. 11 Brooks MA, Ali AN, Turner PC et al. A rabbitpox virus serpin gene controls host range by inhibiting apoptosis in restrictive cells. J. Virol. 1995; 69: 7688-98.
12. 12 Macen JL, Upton C, Nation N et al. SERPI, a serine proteinase inhibitor encoded by myxoma virus, is a secreted glycoprotein that interferes with inflammation. Virology 1993; 195: 348-63.
13. 13 Nash P, Whitty A, Handwerker J et al. Inhibitory specificity of the anti-inflammatory myxoma virus serpin, SERP-1. J. Biol. Chem. 1988; 273: 20 982-91.
14. 14 Petit F, Bertagnoli S, Gelfi J et al. Characterization of a myxoma virus-encoded serpin-like protein with activity against interleukin-1 beta-converting enzyme. J. Virol. 1996; 70: 5860-6.
15. 15 Messud-Petit F, Gelfi J, Delverdier M et al. Serp2, an inhibitor of the interleukin-1beta-converting enzyme, is critical in the pathobiology of myxoma virus. J. Virol. 1998; 72: 7830-9.
16. 16 Tewari M, Telford WG, Miller RA et al. CrmA. a poxvirus-encoded serpin, inhibits cytotoxic T-lymphocyte-mediated apoptosis. J. Biol. Chem. 1995; 270: 22 705-8.
17. 17 Quan LT, Caputo A, Bleackley RC et al. Granzyme B is inhibited by the cowpox virus serpin cytokine response modifier A. J. Biol. Chem. 1995; 270: 10 377-9.
18. 18 Ray CA, Black RA, Kronheim SR et al. Viral inhibition of inflammation: Cowpox virus encodes an inhibitor of the interleukin-1 beta converting enzyme. Cell 1992; 69: 597-604.
19. 19 Zhou Q, Snipas S, Orth K et al. Target protease specificity of the viral serpin CrmA. Analysis of five caspases. J. Biol. Chem. 1997; 272: 7797-800.
20. 20 Howard ST, Chan YS, Smith GL. Vaccinia virus homologues of the Shope fibroma virus inverted terminal repeat proteins and a discontinuous ORF related to the tumor necrosis factor receptor family. Virology 1991; 180: 633-47.
21. 21 Smith CA, Davis T, Wignall JM et al. T2 open reading frame from the Shope fibroma virus encodes a soluble form of the TNF receptor. Biochem. Biophys. Res. Commun. 1991; 176: 335-42.
22. 22 Upton C, Macen JL, Schreiber M et al. Myxoma virus expresses a secreted protein with homology to the tumor necrosis factor receptor gene family that contributes to viral virulence. Virology 1991; 184: 370-82.
23. 23 Hu FQ, Smith CA, Pickup DJ. Cowpox virus contains two copies of an early gene encoding a soluble secreted form of the type II TNF receptor. Virology 1994; 204: 343-56.
24. 24 Smith CA, Hu FQ, Smith TD et al. Cowpox virus genome encodes a second soluble homologue of cellular TNF receptors, distinct from CrmB, that binds TNF but not LT alpha. Virology 1996; 223: 132-47.
25. 25 Mossman K, Upton C, Buller RM et al. Species specificity of ectromelia virus and vaccinia virus interferon-gamma binding proteins. Virology 1995; 208: 762-9.
26. 26 Upton C, Mossman K, McFadden G. Encoding of a homolog of the IFN-gamma receptor by myxoma virus. Science 1992; 258: 1369-72.
27. 27 Symons JA, Alcami A, Smith GL. Vaccinia virus encodes a soluble type 1 interferon receptor of novel structure and broad species specificity. Cell 1995; 81: 551-60.
28. 28 Alcami A, Smith GL. A soluble receptor for interleukin-1 beta encoded by vaccinia virus: A novel mechanism of virus modulation of the host response to infection. Cell 1992; 71: 153-67.
29. 29 Spriggs MK, Hruby DE, Maliszewski CR et al. Vaccinia and cowpox viruses encode a novel secreted interleukin-1-binding protein. Cell 1992; 71: 145-52.
30. 30 Alcami A, Smith GL. A mechanism for the inhibition of fever by a virus. Proc: Natl Acad. Sci. USA 1996; 93: 11 029-34.
31. 31 Palumbo GJ, Buller RM, Glasgow WC. Multigenic evasion of inflammation by poxviruses. J. Virol. 1994; 68: 1737-49.
32. 32 Kuida K, Lippke JA, Ku G et al. Altered cytokine export and apoptosis in mice deficient in interleukin-1 beta converting enzyme. Science 1995; 267: 2000-3.
33. 33 Li P, Allen H, Banerjee S et al. Mice deficient in IL-1 beta-converting enzyme are defective in production of mature IL-1 beta and resistant to endotoxic shock. Cell 1995; 80: 401-11.
34. 34 O'Neill LA, Greene C. Signal transduction pathways activated by the IL-1 receptor family: Ancient signaling machinery in mammals, insects, and plants. J. Leukoc. Biol. 1998; 63: 650-7.
35. 35 Smith GL, Chan YS. Two vaccinia virus proteins structurally related to the interleukin-1 receptor and the immunoglobulin superfamily. J. Gen. Virol. 1991; 72: 511-18.
36. 36 Kettle S, Alcami A, Khanna A et al. Vaccinia virus serpin B13R (SPI-2) inhibits interleukin-1 beta-converting enzyme and protects virus-infected cells from TNF-and Fas-mediated apoptosis, but does not prevent IL-1beta-induced fever. J. Gen. Virol. 1997; 78: 677-85.
37. 37 Karupiah G, Blanden RV, Ramshaw IA. Interferon gamma is involved in the recovery of athymic nude mice from recombinant vaccinia virus/interleukin 2 infection. J. Exp. Med. 1990; 172: 1495-503.
38. 38 Kohonen-Corish M, King NJ, Woodhams CE et al. Immunodeficient mice recover from infection with vaccinia virus expressing interferon-gamma. Eur. J. Immunol. 1990; 20: 157-61.
39. 39 Huang S, Hendriks W, Althage A et al. Immune response in mice that lack the interferon-γ receptor. Science 1993; 259: 1742-5.
40. 40 Karupiah G, Xie QW, Buller RM et al. Inhibition of viral replication by interferon-gamma-induced nitric oxide synthase. Science 1993; 261: 1445-8.
41. 41 Beattie E, Tartaglia J, Paoletti E. Vaccinia virus-encoded eIF-2 alpha homolog abrogates the antiviral effect of interferon. Virology 1991; 183: 419-22.
42. 42 Beattie M, Denzler KL, Tartaglia J et al. Reversal of the interferon-sensitive phenotype of a vaccinia virus lacking E3L by expression of the reovirus S4 gene. J. Virol. 1995; 69: 499-505.
43. 43 Beattie E, Paoletti E, Tartaglia J. Distinct patterns of IFN sensitivity observed in cells infected with vaccinia K3L-and E3L-mutant viruses. Virology 1995; 210: 254-63.
44. 44 Okamura H, Tsutsi H, Komatsu T et al. Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature 1995; 378: 88-91.
45. 45 Bazan JF, Timans JC, Kastelein RA. A newly defined interleukin-1? Nature 1996; 379: 591.
46. 46 Ghayur T, Banerjee S, Hugunin M et al. Caspase-1 processes IFN-gamma-inducing factor and regulates LPS-induced 1FN-gamma production. Nature 1997; 386: 619-23.
47. 47 Gu Y, Kuida K, Tsutsui H et al. Activation of interferon-gamma inducing factor mediated by interleukin-1beta converting enzyme. Science 1997; 275: 206-9.
48. 48 Fantuzzi G, Puren AJ, Harding MW et al. Interleukin-18 regulation of interferon gamma production and cell proliferation as shown in interleukin-1 beta-converting enzyme (caspase-1)-deficient mice. Blood 1998; 91: 2118-25.
49. 49 Kohno K, Kataoka J, Ohtsuki T et al. IFN-gamma-inducing factor (1G1F) is a costimulatory factor on the activation of Th1 but not Th2 cells and exerts its effect independently of IL-12. J. Immunol. 1997; 158: 1541-50.
50. 50 Dao T, Mehal WZ, Crispe IN. IL-18 augments perforin-dependent cytotoxicity of liver NK-T cells. J. Immunol. 1998; 161: 2217-22.
51. 51 Ashkenazi A, Dixit VM. Death receptors: Signaling and modulation. Science 1998; 281: 1305-8.
52. 52 Evan G, Littlewood T. A matter of life and cell death. Science 1998; 281: 1317-22.
53. 53 Vaux DL, Haecker G, Strasser A. An evolutionary perspective on apoptosis. Cell 1994; 76: 777-9.
54. 54 Razvi ES, Welsh RM. Apoptosis in viral infections. Adv. Virus Res. 1995; 45: 1-60.
55. 55 Turner P, Moyer R. Control of apoptosis by poxviruses. Semin. Virol. 1998; 8: 453-69.
56. 56 Sleath PR, Hendrickson RC, Kronheim SR et al. Substrate specificity of the protease that processes human interleukin-1 beta. J. Biol. Chem. 1990; 265: 14 526-8.
57. 57 Howard AD, Kostura MJ, Thornberry N et al. IL-1-converting enzyme requires aspartic acid residues for processing of the II.-1 beta precursor at two distinct sites and does not cleave 31-kDa IL-1 alpha. J. Immunol. 1991; 147: 2964-9.
58. 58 Thornberry NA, Bull HG, Calaycay JR et al. A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes. Nature 1992; 356: 768-74.
59. 59 Yuan J, Shaham S, Ledoux S et al. The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1 beta-converting enzyme. Cell 1993; 75: 641-52.
60. 60 Kuida K, Zheng TS, Na S et al. Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice. Nature 1996; 384: 368-72.
61. 61 Varfolomcev EE, Schuchmann M, Luria V et al. Targeted disruption of the mouse Caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apol, and DR3 and is lethal prenatally. Immunity 1998; 9: 267-76.
62. 62 Wang S, Miura M, Jung Y-K et al. Murine caspase-11, an ICE-interacting protease, is essential for the activation of ICE. Cell 1998; 92: 501-9.
63. 63 Li P, Allen H, Banerjee S et al. Characterization of mice deficient in interleukin-1 beta converting enzyme. J. Cell. Biochem. 1997; 64: 27-32.
64. 64 Kuida K, Haydar, TF, Kuan CY et al. Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking caspase 9. Cell 1998; 94: 325-37.
65. 65 Hakem R, Hakem A, Duncan GS et al. Differential requirement for caspase 9 in apoptotic pathways in vivo. Cell 1998; 94: 339-52.
66. 66 Miller DK, Ayala JM, Egger LA et al. Purification and characterization of active human interleukin-1 beta-converting enzyme from THP.1 monocytic cells. J. Biol. Chem. 1993; 268: 18 062-9.
67. 67 Ayala JM, Yamin TT, Egger LA et al. IL-1 beta-converting enzyme is present in monocytic cells as an inactive 45-kDa precursor. J. Immunol. 1994; 153: 2592-9.
68. 68 Wang S, Miura M, Jung YK et al. Identification and characterization of Ich-3, a member of the interleukin-1beta converting enzyme (ICE)/Ced-3 family and an upstream regulator of ICE. J. Biol. Chem. 1996; 271: 20 580-7.
69. 69 Miura M, Zhu H, Rotello R et al. Induction of apoptosis in fibroblasts by IL-1 beta-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3. Cell 1993; 75: 653-60.
70. 70 Nicholson DW, Ali A, Thornberry NA et al. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 1995; 376: 37-43.
71. 71 Schotte P, van Crickinge W, van de Craen M et al. Cathepsin B-mediated activation of the proinflammatory caspase-11. Biochem. Biophys. Res. Commun. 1998; 251: 379-87.
72. 72 Smith DJ, McGuire MJ, Tocci MJ et al. II.-1 beta convertase (ICE) does not play a requisite role in apoptosis induced in T lymphoblasts by Fas-dependent or Fas-independent CTI. effector mechanisms. J. Immunol. 1997; 158: 163-70.
73. 73 Friedlander RM, Gagliardini V, Hara H et al. Expression of a dominant negative mutant of interleukin-1 beta converting enzyme in transgenic mice prevents neuronal cell death induced by trophic factor withdrawal and ischemic brain injury. J. Exp. Med. 1997; 185: 933-40.
74. 74 Smith KG, Strasser A, Vaux DL. CrmA expression in T lymphocytes of transgenic mice inhibits CD95 (Fas/APO-1)-transduced apoptosis, but does not cause lymphadenopathy or autoimmune disease. Embo J. 1996; 15: 5167-76.
75. 75 Friedlander RM, Gagliardini V, Rotello RJ et al. Functional role of interleukin 1 beta(IL-1 beta) in IL-1 beta-converting enzyme-mediated apoptosis. J. Exp. Med. 1996; 184: 717-24.
76. 76 Muzio M, Salvesen GS, Dixit VM. FLICE induced apoptosis in a cell-free system. Cleavage of caspase zymogens. J. Biol. Chem. 1997; 272: 2952-6.
77. 77 Miura M, Friedlander RM, Yuan J. Tumor necrosis factor-induced apoptosis is mediated by a CrmA-sensitive cell death pathway. Proc. Natl Acad. Sci. USA 1995; 92: 8318-22.
78. 78 Tewari M, Dixit VM. Fas-and tumor necrosis factor-induced apoptosis is inhibited by the poxvirus crmA gene product. J. Biol. Chem. 1995; 270: 3255-60.
79. 79 Enari M, Hug H, Hayakawa M et al. Different apoptotic pathways mediated by Fas and the tumor-necrosis-factor receptor. Cytosolic phospholipase A2 is not involved in Fas-mediated apoptosis. Eur. J. Biochem. 1996; 236: 533-8.
80. 80 Dobbelstein M, Shenk T. Protection against apoptosis by the vaccinia virus SPI-2 (B13R) gene product. J. Virol. 1996; 70: 6479-85.
81. 81 Macen JL, Garner RS, Musy PY et al. Differential inhibition of the Fas-and granule-mediated cytolysis pathways by the orthopoxvirus cytokine response modifier A/SPI-2 and SPI-1 protein. Proc. Natl Acad. Sci. USA 1996; 93: 9108-13.
82. 82 Garcia-Calvo M, Peterson EP, Leiting B et al. Inhibition of human caspases by peptide-based and macromolecular inhibitors. J. Biol. Chem. 1998; 273: 32 608-13.
83. 83 Froclich C, Dixit V, Yang X. Lymphocyte granule-mediated apoptosis: Matters of viral mimicry and deadly proteases. Immunol. Today 1998; 19: 30-6.
84. 84 Albert ML, Sauter B, Bhardwaj N. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 1998; 392: 86-9.
85. 85 Carbone FR, Kurts C, Bennett SR et al. Cross-presentation: A general mechanism for CTL immunity and tolerance. Immunol. Today 1998; 19: 368-73.
86. 86 Kettle S, Blake NW, Law KM et al. Vaccinia virus serpins B13R (SPI-2) and B22R (SPI-1) encode M(r) 38.5 and 40K, intracellular polypeptides that do not affect virus virulence in a murine intranasal model. Virology 1995; 206: 136-47.
87. 87 Macen J, Takahashi A, Moon KB et al. Activation of caspases in pig kidney cells infected with wild-type and CrmA/SPI-2 mutants of cowpox and rabbitpox viruses. J. Virol. 1998; 72: 3524-33.
88. 88 Bird CH, Sutton VR, Sun J et al. Selective regulation of apoptosis: The cytotoxic lymphocyte serpin proteinase inhibitor 9 protects against granzyme B-mediated apoptosis without perturbing the Fas cell death pathway. Mol. Cell. Biol. 1998; 18: 6387-98.